TABLE 2

Results of Treatment

Patient no.Tumor typeTotal activity (GBq)Response (RECIST)Progression-free period (mo)Death (mo)
1MCT11.4CRNoneAlive
2Carcinoid15.2DS810
3Carcinoid36.6DS18Alive
4Carcinoid18.1DS1218
5Carcinoid33.6PRNoneAlive
6Carcinoid3.1DP11*
7Carcinoid16.7DP23
8Gastrinoma12.5DS16Alive
9Carcinoid24.4DS814*
10Carcinoid21.1PRNoneAlive
11MCT10.5CRNoneAlive
12Carcinoid14.8DP24
13Glucagonoma11.6DS8Alive
14Carcinoid23.0DSNoneAlive
15Fibrolamellar12.2DP215
16Malignant histiocytoma7PR14Alive
  • * Patients died from cause other than tumor for which they were being treated.

  • RECIST = response evaluation criteria in solid tumors; CR = complete response; DS = disease stability; PR = partial response; DP = disease progression.